Focus on multiple myeloma - PubMed (original) (raw)

Review

Focus on multiple myeloma

Constantine S Mitsiades et al. Cancer Cell. 2004 Nov.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma.
  Barlogie B, Alexanian R. Barlogie B, et al. Cancer Res. 1989 Dec 15;49(24 Pt 1):7172-5. Cancer Res. 1989. PMID: 2479477 No abstract available.
• FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
  Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, Catley L, Mitsiades CS, Richardson PG, Albert R, Brinkmann V, Chauhan D, Anderson KC. Yasui H, et al. Cancer Res. 2005 Aug 15;65(16):7478-84. doi: 10.1158/0008-5472.CAN-05-0850. Cancer Res. 2005. PMID: 16103102
• Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma.
  Ribatti D, Nico B, Vacca A. Ribatti D, et al. Oncogene. 2006 Jul 20;25(31):4257-66. doi: 10.1038/sj.onc.1209456. Epub 2006 Mar 6. Oncogene. 2006. PMID: 16518413 Review.
• Multiple myeloma in younger age.
  Akhtar K, Laghari NA, Haq AU, Anees M, Rehman SU, Alam MI. Akhtar K, et al. J Coll Physicians Surg Pak. 2009 Jan;19(1):62-3. J Coll Physicians Surg Pak. 2009. PMID: 19149986
• Lenalidomide in multiple myeloma.
  Richardson PG, Mitsiades C, Hideshima T, Anderson KC. Richardson PG, et al. Expert Rev Anticancer Ther. 2006 Aug;6(8):1165-73. doi: 10.1586/14737140.6.8.1165. Expert Rev Anticancer Ther. 2006. PMID: 16925483 Review.

Cited by

• Construct prognostic models of multiple myeloma with pathway information incorporated.
  Wang S, Wang S, Pan W, Yi Y, Lu J. Wang S, et al. PLoS Comput Biol. 2024 Sep 10;20(9):e1012444. doi: 10.1371/journal.pcbi.1012444. eCollection 2024 Sep. PLoS Comput Biol. 2024. PMID: 39255326 Free PMC article.
• Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes.
  Binder M, Szalat RE, Talluri S, Fulciniti M, Avet-Loiseau H, Parmigiani G, Samur MK, Munshi NC. Binder M, et al. Nat Commun. 2024 May 16;15(1):4139. doi: 10.1038/s41467-024-47793-5. Nat Commun. 2024. PMID: 38755155 Free PMC article.
• High-content microscopy reveals a morphological signature of bortezomib resistance.
  Kelley ME, Berman AY, Stirling DR, Cimini BA, Han Y, Singh S, Carpenter AE, Kapoor TM, Way GP. Kelley ME, et al. Elife. 2023 Sep 27;12:e91362. doi: 10.7554/eLife.91362. Elife. 2023. PMID: 37753907 Free PMC article.
• Mathematical reconstruction of the metabolic network in an in-vitro multiple myeloma model.
  Vera-Siguenza E, Escribano-Gonzalez C, Serrano-Gonzalo I, Eskla KL, Spill F, Tennant D. Vera-Siguenza E, et al. PLoS Comput Biol. 2023 Sep 15;19(9):e1011374. doi: 10.1371/journal.pcbi.1011374. eCollection 2023 Sep. PLoS Comput Biol. 2023. PMID: 37713666 Free PMC article.
• High-content microscopy reveals a morphological signature of bortezomib resistance.
  Kelley ME, Berman AY, Stirling DR, Cimini BA, Han Y, Singh S, Carpenter AE, Kapoor TM, Way GP. Kelley ME, et al. bioRxiv [Preprint]. 2023 May 2:2023.05.02.539137. doi: 10.1101/2023.05.02.539137. bioRxiv. 2023. PMID: 37205516 Free PMC article. Updated. Preprint.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information